Loading clinical trials...
Loading clinical trials...
A prospective cohort study, which aims to systematically evaluate biomarkers and potential targets in NAFLD and NASH.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Copenhagen University Hospital, Hvidovre
NCT05623150 · Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, and more
NCT07265544 · Liver Neoplasm, HBV Infection, and more
NCT07403604 · Hyperinsulinemia, Insulin Resistance, and more
NCT06519162 · Autoimmune Hepatitis, Primary Sclerosing Cholangitis, and more
NCT06819917 · Non-alcoholic Fatty Liver, Non-Alcoholic Fatty Liver Disease, and more
Gastrounit, Copenhagen University Hospital Hvidovre
Hvidovre, Capital Region Denmark
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions